Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

IL7Rα contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineages.

Ashbaugh JJ, Brambilla R, Karmally SA, Cabello C, Malek TR, Bethea JR.

J Immunol. 2013 May 1;190(9):4525-34. doi: 10.4049/jimmunol.1203214. Epub 2013 Mar 25.

2.

Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis.

Piccio L, Cantoni C, Henderson JG, Hawiger D, Ramsbottom M, Mikesell R, Ryu J, Hsieh CS, Cremasco V, Haynes W, Dong LQ, Chan L, Galimberti D, Cross AH.

Eur J Immunol. 2013 Aug;43(8):2089-100. doi: 10.1002/eji.201242836. Epub 2013 Jun 7.

3.

Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.

Sonobe Y, Jin S, Wang J, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A.

Tohoku J Exp Med. 2007 Dec;213(4):329-39.

4.

Thymic stromal lymphopoietin deficiency attenuates experimental autoimmune encephalomyelitis.

Eckhardt J, Döbbeler M, König C, Kuczera K, Kuhnt C, Ostalecki C, Zinser E, Mak TW, Steinkasserer A, Lechmann M.

Clin Exp Immunol. 2015 Jul;181(1):51-64. doi: 10.1111/cei.12621. Epub 2015 May 17.

5.

Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.

Rostami A, Ciric B.

J Neurol Sci. 2013 Oct 15;333(1-2):76-87. doi: 10.1016/j.jns.2013.03.002. Epub 2013 Apr 8. Review.

6.

γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis.

Blink SE, Caldis MW, Goings GE, Harp CT, Malissen B, Prinz I, Xu D, Miller SD.

Cell Immunol. 2014 Jul;290(1):39-51. doi: 10.1016/j.cellimm.2014.04.013. Epub 2014 May 10.

7.

Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.

Yin LL, Lin LL, Zhang L, Li L.

Neuropharmacology. 2012 Oct;63(5):851-62. doi: 10.1016/j.neuropharm.2012.06.025. Epub 2012 Jun 21.

PMID:
22728315
8.

Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis.

Kim RY, Hoffman AS, Itoh N, Ao Y, Spence R, Sofroniew MV, Voskuhl RR.

J Neuroimmunol. 2014 Sep 15;274(1-2):53-61. doi: 10.1016/j.jneuroim.2014.06.009. Epub 2014 Jun 24.

9.

CD24 controls expansion and persistence of autoreactive T cells in the central nervous system during experimental autoimmune encephalomyelitis.

Bai XF, Li O, Zhou Q, Zhang H, Joshi PS, Zheng X, Liu Y, Wang Y, Zheng P, Liu Y.

J Exp Med. 2004 Aug 16;200(4):447-58.

10.

Immunization with a peptide of Semliki Forest virus promotes remyelination in experimental autoimmune encephalomyelitis.

Mokhtarian F, Safavi F, Sarafraz-Yazdi E.

Brain Res. 2012 Dec 7;1488:92-103. doi: 10.1016/j.brainres.2012.09.038. Epub 2012 Sep 29.

PMID:
23031637
11.

Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.

Kassis I, Petrou P, Halimi M, Karussis D.

Immunol Lett. 2013 Jul-Aug;154(1-2):70-6. doi: 10.1016/j.imlet.2013.06.002. Epub 2013 Aug 28.

PMID:
23994102
12.

The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis.

Johnson DA, Amirahmadi S, Ward C, Fabry Z, Johnson JA.

Toxicol Sci. 2010 Apr;114(2):237-46. doi: 10.1093/toxsci/kfp274. Epub 2009 Nov 12.

13.

IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system.

Li H, Nourbakhsh B, Cullimore M, Zhang GX, Rostami A.

Eur J Immunol. 2011 Aug;41(8):2197-206. doi: 10.1002/eji.201041125. Epub 2011 Jul 6.

14.

CD24 on the resident cells of the central nervous system enhances experimental autoimmune encephalomyelitis.

Liu JQ, Carl JW Jr, Joshi PS, RayChaudhury A, Pu XA, Shi FD, Bai XF.

J Immunol. 2007 May 15;178(10):6227-35.

15.

IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.

Teige I, Treschow A, Teige A, Mattsson R, Navikas V, Leanderson T, Holmdahl R, Issazadeh-Navikas S.

J Immunol. 2003 May 1;170(9):4776-84.

16.

Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.

Virgili N, Espinosa-Parrilla JF, Mancera P, Pastén-Zamorano A, Gimeno-Bayon J, Rodríguez MJ, Mahy N, Pugliese M.

J Neuroinflammation. 2011 Nov 2;8:149. doi: 10.1186/1742-2094-8-149.

17.

Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.

Murphy AC, Lalor SJ, Lynch MA, Mills KH.

Brain Behav Immun. 2010 May;24(4):641-51. doi: 10.1016/j.bbi.2010.01.014. Epub 2010 Feb 6.

PMID:
20138983
18.

Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit W-sh/W-sh mice.

Piconese S, Costanza M, Musio S, Tripodo C, Poliani PL, Gri G, Burocchi A, Pittoni P, Gorzanelli A, Colombo MP, Pedotti R.

Lab Invest. 2011 Apr;91(4):627-41. doi: 10.1038/labinvest.2011.3. Epub 2011 Feb 14.

19.

Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.

Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, Vodjgani M, Warren KG, Andrade-Gordon P, Hollenberg MD, Power C.

J Exp Med. 2006 Feb 20;203(2):425-35. Epub 2006 Feb 13.

20.

DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.

Bhopale MK, Hilliard B, Constantinescu CS, Fujioka T, Ventura E, Phillips SM, Rostami A.

Exp Mol Pathol. 2014 Feb;96(1):108-17. doi: 10.1016/j.yexmp.2013.07.004. Epub 2013 Jul 17.

PMID:
23872438

Supplemental Content

Support Center